Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Publication Title
Clin Epigenetics
Document Type
Article
Publication Date
7-29-2022
Keywords
california; sjci; santa monica
Clinical Institute
Women & Children
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
COinS